Licensing Agreements
King Pharmaceuticals Acquires License from Gelita Medical to Hemostatic Products
Published in Hospital Business Week, March 11th, 2007
Pursuant to the agreement, King received an exclusive license to market, distribute and sell Gelita's absorbable gelatin sponge in the U.S. Gelita will manufacture and supply the hemostatic product to King under the agreement. King's THROMBIN-JMI(R) (thrombin, topical, bovine, USP), a topical active hemostatic agent, is often used by surgeons together with a variety of passive hemostatic agents, including absorbable gelatin sponges.
Brian A. Markison,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Advanced Research Technologies
ART Receives CE Marking for SoftScan Device - Adverse Drug Reactions
New Version of Devices to Treat Clogged Neck Arteries Approved by U.S. Food and Drug Administration - Aging
ADT Security Services to Continue Roll Out of Its Health Monitoring Solution - Anatomy
MedRisk's ECB Completes Preliminary Validation of a Spanish-Language Patient Satisfaction Measurement Tool for Physical Therapy Care - Anesthesia
Indigo Orb, Inc. Launches Episure AutoDetect Loss of Resistance Syringe in the U.S. - Angiology
Methodist Le Bonheur Healthcare is Nationwide Leader With Breakthrough VeinViewer Imaging System by Luminetx - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
